TABLE 1.

Clinical and Demographic Characteristics

Variable	Total Patients (n = 80)
Mean age (years)	66 ± 9
Number with MRI-targeted biopsies	51 (64)
Number of patients on active surveillance with GG1 prostate cancer	5 (6)
Number of patients classified as PI-RADS 1 with stable or decreasing PSA at 1 year follow-up	24 (30)
Number with csPCa	17 (21)
Number with grade group 2 prostate cancer	10 (12)
Number with grade group 3 prostate cancer	1 (1)
Number with grade group 4 prostate cancer	5 (6)
Number with grade group 5 prostate cancer	1 (1)

Except where indicated, data are numbers of participants with percentages in parentheses.

csPCa = clinically significant prostate cancer (Grade Group 2 or greater). GG = grade group. PI-RADS = Prostate Imaging Reporting and Data System v2.1.